Related Experiment Video
Updated: Jun 17, 2026
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Primary sinonasal malignant melanoma: a clinicopathologic and prognostic study
Sudesh Kumar1, Ashok K Gupta, Budhi S Yadav
1Department of Otolaryngology-Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India. drsudeshkumar@rediffmail.com
Ear, Nose, & Throat Journal
|December 17, 2009
Summary
Primary sinonasal malignant melanoma has a poor prognosis, with distant metastasis being the main cause of death. Aggressive treatment is often insufficient to overcome the disease's aggressive nature.
Area of Science:
- Oncology
- Otorhinolaryngology
- Pathology
Background:
- Primary sinonasal malignant melanoma is a rare and aggressive malignancy.
- Understanding its clinicopathologic features and prognostic factors is crucial for patient management.
Observation:
- A retrospective study reviewed 10 patients with primary sinonasal malignant melanoma.
- Tumor locations included the nasal cavity and paranasal sinuses.
- Treatment modalities varied, including surgery, radiotherapy, and chemotherapy.
Findings:
- The 2- and 5-year survival rates were 60% and 40%, respectively.
- Distant metastasis was the primary cause of mortality, even with locoregional control.
- Factors associated with poor prognosis included older age, paranasal sinus location, advanced stage, external surgical approach, and lack of adjuvant radiotherapy.
Implications:
- Primary sinonasal malignant melanoma carries a generally poor prognosis.
- Distant metastasis highlights the aggressive nature of this cancer.
- Further research into optimizing treatment strategies, including adjuvant therapies, is warranted.
